BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Account Payables
Amounts the company owes suppliers for goods and services received.
BillionToOne, Inc.NASDAQ: BLLN
Account Payables · Q2 FY2026 · quarter ended Jun 2026
Account payables rises 53.6% from a year ago
Account payables stood at $12.21M at the end of Q2 FY2026, up 53.6% from a year earlier and up 40.3% from the prior quarter.
Context
- Account payables amounted to 1.7% of total assets at the end of Q2 FY2026, down 0.9 pp from a year earlier.
- Account payables increased in 2 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +53.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 7.18M USD
- Year-over-year change
- +66.9%
- 2-year CAGR
- +49.6%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 7.18M | +66.9% |
| FY2024 | 2024-12-31 | 4.3M | +34.0% |
| FY2023 | 2023-12-31 | 3.21M | — |
Account Payables vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 account payables of $12.21M is the 6th highest of the 9 companies compared; the peer median is $26.86M.
- Its year-over-year change of +53.6% is the 4th highest of 9, against a peer median of +31.1%.
- Account payables amounts to 1.7% of total assets for BLLN, versus a peer median of 2.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $102.51M | +408.9% | -7.6% | 5.4% | |
| Jun 2026 | $100.46M | +265.4% | +4.0% | 7.4% | |
| Jun 2026 | $75.15M | +103.8% | +2.1% | 2.8% | |
| Mar 2026 | $32.6M | +16.0% | +1.4% | 4.8% | |
| Mar 2026 | $21.13M | +15.8% | -6.9% | 1.8% | |
BLLNBillionToOne, Inc. | Jun 2026 | $12.21M | +53.6% | — | 1.7% |
| Jun 2026 | $8.02M | -29.9% | -27.2% | 0.5% | |
| Jun 2026 | $7.24M | +15.2% | -50.8% | 0.3% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $5.15M | +46.1% | -62.3% | 1.1% |
| Peer median (excluding BLLN) | $26.86M | +31.1% | -7.2% | 2.3% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.